Bone remodeling is traditionally driven by osteoblasts and osteoclasts, but our study reveals a third essential player: "Type R capillaries". Excited to share my PhD work from Ralf H. Adams lab, now published in Nature Cell Biology. nature.com/articles/s4155… 🧵1/8👇 🐭🔬🦴

That feeling of placing the last slides of the group right as the clock ticks over to 5:00 Yale Department of Orthopaedics and Rehabilitation #histology #bone

New data in #JBMRPlus from a multicenter cohort demonstrated that sequential therapy from teriparatide to romosozumab exhibited greater benefits in increasing BMD at any site than romosozumab to teriparatide. #freetoread #openaccess ASBMR Read more here: ow.ly/SiZc50U5g3K

One of the reasons why it is so difficult to maintain weight loss is because adipose issue retains an epigenetic memory of obesity after weight loss. nature.com/articles/s4158…

What are we staining today? Some pretty osteoclasts (and a few osteocytes) with TRAP on FFPE sections #histology #bone

That's my Representative. Thank you Rosa DeLauro for your words

Findings in this #JBMRPlus article suggest that osteocytes potentially play a significant role in the post-traumatic systemic response to fracture, though the effects differ between trabecular and cortical bone Benjamin Osipov Sophie Orr Read more here: ow.ly/5FT550U5vw8

Diabetic Kidney Disease: Novel Treatment Approach May Help Prevent Fibrosis, Study Shows m.yale.edu/czgc

Bone marrow endothelial cells do not decline in aging 👇 pmc.ncbi.nlm.nih.gov/articles/PMC49… How can VEGFR3 staining distinguished from Flt4-CreERT2 R26-mTmG mice signals Nature Cell Biology Nature Portfolio Tamoxifen & analysis timepoint areas in diaphysis lack GFP but not VEGR3 staining

A new publication is a great way to start off 2025 nature.com/articles/s4142…

We really appreciate this commentary on our latest publication in Cell Research Nature Portfolio Yale Department of Orthopaedics and Rehabilitation nature.com/articles/s4142…

The January issue of Cell Research is now live! This month’s issue identifies Tau, an infamous player in Alzheimer’s and other neurodegenerative diseases, as a low-affinity receptor for glucocorticoids, driving their side effects such as osteoporosis (GIO). Discover 5

🧪Tau(t)ing glucocorticoid binding The Highlight authored by Jan Tuckermann, which was published in Cell Research, discusses the recent breakthrough regarding glucocorticoid receptor. Key insight: Tau, rather than canonical GR, mediates GC-related adverse effects, particularly

I am so appreciative and excited to be included in this project. It's the cover story for this month! chuanju Liu Yale Department of Orthopaedics and Rehabilitation Yale School of Medicine

Pitt to pause PhD admissions, following Vanderbilt and USC, because of uncertainty of NIH funding to academic universities. Who will teach and train US scientists for pharma and biotech? Should we import them from countries that do? wesa.fm/health-science…

This brings to mind the 3 month pase where my daughter would cry incessantly on car trips unless all conversations were sung to the tune of "Twinkle twinkle little star" How did we figure this out? Desperation? Kids. LOL

Thank you to the ECTS for inving me to talk at #ECTS2025 I had a wonderful time getting to know so many of you and appreciate the opportunity to educate on the biology of CKD-MBD

cnn.com/2025/07/01/hea…